The Magazine for Sleep Professionals
Friday, March 20, 2026
The use of e-cigarettes is associated with wheezing and shortness of breath in young adults and adolescents, even in those who don’t smoke cigarettes or marijuana, according to research presented at the ATS 2021 International Conference. Alayna P. Tackett, PhD, assistant professor of preventive medicine, University of Southern California Keck […]
The American Journal of Endocannabinoid Medicine published a new, independent study that evaluated Good Night pulse technology cannabis sleep aid, scientifically developed and manufactured by Maryland-based health and wellness company Curio Wellness. The study demonstrates a correlation between cannabis and better-quality sleep and proves the effectiveness of the sleep aid. The new sleep […]
With growing interest in its potential health benefits and new legislation favoring legalization in more states, cannabis use is becoming more common among older adults. University of California San Diego School of Medicine researchers report that older adults use cannabis primarily for medical purposes to treat a variety of common […]
Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. In “Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise […]
Melbourne, Australia based nasal respiratory company Rhinomed is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC (“Columbia Care”) to license Rhinomed’s nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogs and derivatives. The non-binding term sheet sets out proposed terms […]
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Millions of people who suffer from some form of insomnia. Whether it be brief symptoms or chronic, not getting the recommended amount of sleep is something that can affect everyday life. Lack of sleep can cause lower productivity and could be dangerous. CURE Pharmaceutical is working on a way to […]
